XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 44 filers reported holding XBIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 164 | -65.3% | 0.00% | – |
Q2 2023 | $2 | – | 473 | +456.5% | 0.00% | – |
Q1 2023 | $0 | – | 85 | -41.8% | 0.00% | – |
Q2 2022 | $0 | – | 146 | +217.4% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 46 | -68.5% | 0.00% | – |
Q4 2021 | $1,000 | -99.3% | 146 | -98.4% | 0.00% | – |
Q3 2021 | $153,000 | +2.0% | 9,275 | +2.2% | 0.00% | – |
Q2 2021 | $150,000 | +341.2% | 9,075 | +352.4% | 0.00% | – |
Q1 2021 | $34,000 | -24.4% | 2,006 | -39.3% | 0.00% | – |
Q2 2020 | $45,000 | -67.9% | 3,305 | -75.1% | 0.00% | – |
Q1 2020 | $140,000 | +68.7% | 13,267 | +195.4% | 0.00% | – |
Q4 2019 | $83,000 | +4050.0% | 4,491 | +1787.0% | 0.00% | – |
Q3 2019 | $2,000 | -83.3% | 238 | -79.6% | 0.00% | – |
Q1 2019 | $12,000 | 0.0% | 1,167 | -71.4% | 0.00% | – |
Q3 2018 | $12,000 | +140.0% | 4,082 | +230.8% | 0.00% | – |
Q2 2018 | $5,000 | -84.8% | 1,234 | -80.4% | 0.00% | -100.0% |
Q1 2018 | $33,000 | +43.5% | 6,310 | +24.1% | 0.00% | 0.0% |
Q2 2017 | $23,000 | -92.2% | 5,085 | -71.7% | 0.00% | -92.3% |
Q1 2017 | $295,000 | +446.3% | 17,941 | +339.1% | 0.01% | +225.0% |
Q3 2016 | $54,000 | – | 4,086 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Capital Impact Advisors, LLC | 52,289 | $862,000 | 0.34% |
ACUTA CAPITAL PARTNERS, LLC | 60,000 | $989,000 | 0.23% |
ACUTA CAPITAL PARTNERS, LLC | 20,000 | $330,000 | 0.08% |
FNY Partners Fund LP | 19,014 | $313,000 | 0.04% |
SIMPLEX TRADING, LLC | 17,941 | $295,000 | 0.01% |
SYNOVUS FINANCIAL CORP | 17,672 | $291,000 | 0.01% |
Virtu KCG Holdings LLC | 11,298 | $186,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 65,000 | $1,072,000 | 0.01% |
Cutler Group LLC / CA | 18,600 | $64,000 | 0.00% |
ProShare Advisors LLC | 19,338 | $319,000 | 0.00% |